Industry Responds to FDA’s Quality Metrics Initiative with Proposal to Report Trends, not Values
This article was originally published in The Gold Sheet
Executive Summary
Industry, FDA explore why manufacturers should report absolute value of quality metrics, not just the trends. FDA’s Woodcock suggests potential reward of reduced inspections by not only FDA, but also by other inspectorates.